Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.
Saved in:
| Title: | Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program. |
|---|---|
| Authors: | Siu DHW; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Illawarra Cancer Care Centre, Wollongong, NSW, Australia., Lin FPY; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia., Thomas DM; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Thavaneswaran S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia., Espinoza D; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Chinchen S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Ballinger ML; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Simes RJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia. |
| Source: | Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1965-1974. Date of Electronic Publication: 2026 Jun 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
